
By Michael Erman
NEW YORK (Reuters) -The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the agency's top officials said on Wednesday.
FDA Commissioner Marty Makary and Chief Medical and Scientific Officer Vinay Prasad said in an essay published in the New England Journal of Medicine that for certain conditions, companies could rely on appropriately designed studies with small sample sizes rather than randomized trials. They will rely on biological plausibility and clinical improvements in those early patients.
"Current regulations are onerous and unnecessarily demanding," Makary and Prasad wrote. "For patients and families, there is no time to wait."
The new "plausible-mechanism" pathway would allow the agency to grant marketing authorization after manufacturers demonstrate success with several consecutive patients.
Companies that receive these approvals will be required to collect real-world evidence to confirm efficacy continues and to look for safety issues that might arise.
The new approach will prioritize treatments for rare diseases that are fatal or cause severe childhood disability. Common diseases with unmet medical needs may also qualify.
While makers of cell and gene therapies are likely to be significant beneficiaries of the new approval process, Makary and Prasad said that other types of treatments could also receive licensure this way.
"The FDA will work as a partner and guide in ushering these therapies to market," the officials wrote.
(Reporting by Michael ErmanEditing by Bill Berkrot)
latest_posts
- 1
Pick Your #1 Sort Of Espresso - 2
Russia Establishing Long-Range Drone Bases In Belarus, Warns Ukraine - 3
Instructions to Pick the Right Dental Embed Trained professional: An Exhaustive Aide - 4
Cyclone causes blackout, flight chaos in Brazil's Sao Paulo - 5
Germany's Pistorius: NATO protects Europe from Iranian missiles
Flu surges across U.S. as doctor visits reach highest level since 1997
As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
Moscow: Russia well-positioned to withstand oil market shocks
37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
What's Your #1 Pizza Beating Mix?
A Concise History Of The Entertainment world
Crew-11 astronauts undock in 1st-ever medical evacuation from the International Space Station (video)
2025 Yachting Editors' Choice Awards: Yachts
Must-Have Cooking Machine in Your Kitchen













